The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: The Tromsø Study

European Journal of Endocrinology

Volumn 158, Issue 3, 2008, Pages 401-409

  Sneve, Monica ^a   Emaus, Nina ^b   Joakimsen, Ragnar Martin ^a,b   Jorde, Rolf ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOREARM; HIP; HUMAN; LIFESTYLE; MALE; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; SMOKING CESSATION;

AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FOREARM; HIP JOINT; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; NORWAY; OSTEOPOROSIS; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING;

EID: 40949113107     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0610     Document Type: Article

References (34)

1. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002 359 1841-1850.
2. Dennison E, Mohamed MA & Cooper C. Epidemiology of osteoporosis. Rheumatic Diseases Clinics of North America 2006 32 617-629.
3. Hamann KL & Lane NE. Parathyroid hormone update. Rheumatic Diseases Clinics of North America 2006 32 703-719.
4. Brown EM & Chen CJ. Calcium, magnesium and the control of PTH secretion. Bone and Mineral 1989 5 249-257.
5. Murray TM, Rao LG, Divieti P & Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocrine Reviews 2005 26 78-113.
6. Jorde R & Sundsfjord J. Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism. The Tromsø Study. Journal of Internal Medicine 2000 247 325-330.
7. Hagstrom E, Lundgren E, Mallmin H, Rastad J & Hellman P. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. Journal of Internal Medicine 2006 259 191-198.
8. Sahota O, Mundey MK, San P, Godber IM, Lawson N & Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004 35 312-319.
9. Hudson JQ. Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies. Annals of Pharmacotherapy 2006 40 1584-1593.
10. Saquib N, von Mühlen D, Garland C & Barrett-Connor E. Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study. Osteoporosis International 2006 17 1734-1741.
11. von Mühlen D, Greendale G, Garland C, Wan L. & Barrett-Connor E. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporosis International 2005 16 1721-1726.
12. Garnero P, Munoz F, Sornay-Rendu E & Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 2007 40 716-722.
13. Szulc P, Munoz F, Marchand F, Chapuy MC & Delmas PD. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS Study. Calcified Tissue International 2003 73 520-530.
14. Ward K & Klesges R. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcified Tissue International 2001 68 259-270.
15. Brot C, Jorgensen NR & Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. European Journal of Clinical Nutrition 1999 53 920-926.
16. Jorde R, Saleh F, Figenschan Y, Kamycheva E, Haug E & Sundsfjord J. Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study. European Journal of Endocrinology 2005 152 39-45.
17. Law MR & Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997 315 841-846.
18. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. American Journal of Obstetrics and Gynecology 2006 194 (Supp 1) S3-S11.
19. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples AL, Wilson PWF & Kiel DP. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone and Mineral Research 2000 15 710-720.
20. Lorentzon M, Mellstrom D, Haug E & Ohlsson C. Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. Journal of Clinical Endocrinology and Metabolism 2007 92 497-503.
21. Gerdhem P & Obrant KJ. Effects of cigarette-smoking on bone mass as assessed by dual-energy x-ray absorptiometry and ultrasound. Osteoporosis International 2002 13 932-936.
22. Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F & Delmas PD. Increased bone resorption in moderate smokers with low body weight: the Minos Study. Journal of Clinical Endocrinology and Metabolism 2002 87 666-674.
23. Thelle DS, Førde OH, Try K & Lehmann EH, The Tromsø heart study. Methods and main results of the cross-sectional study. Acta Medica Scandinavica 1976 200 107-118.
24. Emaus N, Berntsen GKR, Joakimsen R & Fønnebø V Longitudinal changes in forearm bone mineral density in women and men aged 45-84 years: The Tromsø Study, a Population-based Study. American Journal of Epidemiology 2006 5 441-449.
25. Jorde R, Bonaa KH & Sundsfjord J. Primary hyperparathyroidism detected in a health screening. the Tromsø study. Journal of Clinical Epidemiology 2000 53 1164-1169.
26. Kamycheva E, Sundsfjord J & Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. European Journal of Endocrinology 2004 151 167-172.
27. Pluijm SMF, Visser M, Smit JH, Popp-Snijders C, Roos JC & Lips P. Determinants of bone mineral density in older men and women: body composition as mediator. Journal of Bone and Mineral Research 2001 16 2142-2151.
28. Duan Y, De Luca V & Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. Journal of Clinical Endocrinology and Metabolism 1999 84 718-722.
29. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews 2000 21 115-137.
30. Sellmeyer D, Black D, Palermo L, Greenspan S, Ensrud K, Bilezikian J & Rosen C. Heterogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporosis International 2007 18 973-979.
31. Saleh F, Jorde R & Sundsfjord J. Effect of calcium supplementation on blood pressure in patients with secondary hyperparathyroidism. Journal of Endocrinological Investigation 2003 26 35-41.
32. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews 2001 22 477-501.
33. Kapoor D & Jones TH. Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology 2005 152 491-499.
34. Need AG, Kemp A, Giles N, Morris HA, Horowitz M & Nordin BEC. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporosis International 2002 13 83-88.